Barbara Ryan
Director at Indivior PLC (INDV); Director at Indivior Pharmaceuticals, Inc. (INDV); Director at MiNK Therapeutics, Inc. (INKT)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-15.1%
vs. S&P 500-11.0%
Beat the market0%
Paper profit on buys+$480
Total bought / sold$29K / $47K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 5SEC | INKTMiNK Therapeutics, Inc. | Sell | 50022,969 held (−2%) | $12.68 | $6K | -15.5% |
| Jun 5SEC | INKTMiNK Therapeutics, Inc. | Sell | 1,00021,969 held (−4%) | $12.80 | $13K | -16.2% |
| Mar 13SEC | INDVIndivior Pharmaceuticals, Inc. | Buy | 85,724 held (+0%) | $31.09 | $249 | +15.2% |
| Mar 11SEC | INKTMiNK Therapeutics, Inc. | Sell | 20021,706 held (−1%) | $10.17 | $2K | +5.4% |
| Mar 11SEC | INKTMiNK Therapeutics, Inc. | Sell | 30021,406 held (−1%) | $15.28 | $5K | -29.8% |
| Mar 11SEC | INKTMiNK Therapeutics, Inc. | Sell | 50020,906 held (−2%) | $15.57 | $8K | -31.1% |
| Mar 11SEC | INKTMiNK Therapeutics, Inc. | Sell | 50020,406 held (−2%) | $15.30 | $8K | -29.9% |
| Mar 11SEC | INDVIndivior Pharmaceuticals, Inc. | Buy | 315,716 held (+1%) | $32.56 | $1K | +10.0% |
| Mar 4SEC | INKTMiNK Therapeutics, Inc. | Sell | 40022,006 held (−2%) | $10.86 | $4K | -1.3% |
| Mar 4SEC | INKTMiNK Therapeutics, Inc. | Sell | 10021,906 held (−0%) | $10.83 | $1K | -1.0% |
| Jan 7SEC | INDVIndivior PLC | Buy | 7751,963 held (+65%) | $35.39 | $27K | +1.2% |
- Buy
Director Barbara Ryan bought $27K of INDV at $35.39 — first open-market purchase in our records; raises the stake by 65%.